High-risk Population for Gastric Cancer Development Based on Serum Pepsinogen Status and Lifestyle Factors

Helicobacter ◽  
2009 ◽  
Vol 14 (2) ◽  
pp. 81-86 ◽  
Author(s):  
Yutaka Yamaji ◽  
Hirotsugu Watabe ◽  
Haruhiko Yoshida ◽  
Takao Kawabe ◽  
Ryoichi Wada ◽  
...  
2008 ◽  
Vol 134 (4) ◽  
pp. A-482
Author(s):  
Yutaka Yamaji ◽  
Hirotsugu Watabe ◽  
Takao Kawabe ◽  
Toru Mitsushima ◽  
Masao Omata

2005 ◽  
Vol 96 (10) ◽  
pp. 713-720 ◽  
Author(s):  
Hiroshi Ohata ◽  
Masashi Oka ◽  
Kimihiko Yanaoka ◽  
Yasuhito Shimizu ◽  
Chizu Mukoubayashi ◽  
...  

2020 ◽  
Vol 158 (6) ◽  
pp. S-761
Author(s):  
Alexander Tonthat ◽  
Angeli Bernardo ◽  
James L. Buxbaum ◽  
Thomas Zarchy

2021 ◽  
Vol 32 (10) ◽  
pp. 589-869
Author(s):  
Jiang Zhang Xiu ◽  
◽  
Nong Bing ◽  
Ning Jia Juan ◽  
Huang Peng Yu ◽  
...  

2006 ◽  
Vol 192 (4) ◽  
pp. 474-477 ◽  
Author(s):  
Jennifer Chun ◽  
Mahmoud El-Tamer ◽  
Kathie-Ann Joseph ◽  
Beth Ann Ditkoff ◽  
Freya Schnabel

2015 ◽  
Vol 148 (4) ◽  
pp. S-566 ◽  
Author(s):  
Niraj Jani ◽  
Ravi Kankotia ◽  
James L. Buxbaum ◽  
Alex Shindel ◽  
Ben Da ◽  
...  

2018 ◽  
Vol 146 (14) ◽  
pp. 1834-1840 ◽  
Author(s):  
A. Kowada

AbstractGastric cancer is the third leading cause of cancer death worldwide. Gastric cancer screening using upper gastrointestinal series, endoscopy and serological testing has been performed in population-based (employee-based and community-based) and opportunistic cancer screening in Japan. There were 45 531 gastric cancer deaths in 2016, with the low screening and detection rates.Helicobacter pylori(H. pylori) screening followed by eradication treatment is recommended in high-risk population settings to reduce gastric cancer incidence. The aim of this study was to evaluate the cost-effectiveness ofH. pyloriscreening followed by eradication treatment for a high-risk population in the occupational health setting. Decision trees and Markov models were developed for two strategies;H. pyloriantibody test (HPA) screening and no screening. Targeted populations were hypothetical cohorts of employees aged 20, 30, 40, 50 and 60 years using a company health payer perspective on a lifetime horizon. Per-person costs and effectiveness (quality-adjusted life-years) were calculated and compared. HPA screening yielded greater benefits at the lower cost than no screening. One-way and probabilistic sensitivity analyses using Monte-Carlo simulation showed strong robustness of the results.H. pyloriscreening followed by eradication treatment is recommended to prevent gastric cancer for employees in Japan, on the basis of cost-effectiveness.


Sign in / Sign up

Export Citation Format

Share Document